Cargando…

14B. Buyang Huanwu Decoction for Post-stroke Sequelae (Qi And Blood Stasis): A Systematic Review of Randomized Controlled Trials

Focus Area: Integrative Approaches to Care OBJECTIVE: Currently, Buyang Huanwu Decoction (BHD) used alone or integrated with Western drugs has been widely used as an alternative and effective method for the treatment of stroke of sequelae in China. Many clinical studies reported the effectiveness ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Juah, Choi, Tae-Young, Ko, Mimi, Lee, Jungsup, Lee, Myeong Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Global Advances in Health and Medicine 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875090/
http://dx.doi.org/10.7453/gahmj.2013.097CP.S14B
_version_ 1782297326739521536
author Lee, Juah
Choi, Tae-Young
Ko, Mimi
Lee, Jungsup
Lee, Myeong Soo
author_facet Lee, Juah
Choi, Tae-Young
Ko, Mimi
Lee, Jungsup
Lee, Myeong Soo
author_sort Lee, Juah
collection PubMed
description Focus Area: Integrative Approaches to Care OBJECTIVE: Currently, Buyang Huanwu Decoction (BHD) used alone or integrated with Western drugs has been widely used as an alternative and effective method for the treatment of stroke of sequelae in China. Many clinical studies reported the effectiveness ranging from case reports and case series to controlled observational studies and randomized clinical trials, but the evidence for its effect is not clear. Our objective was to evaluate the clinical efficacy of Buyang Huanwu decoction (BHD) in treating sequelae of stroke. METHODS: Thirteen databases were searched from their inception through January 2013. Randomized clinical trials (RCTs) were included if BHD was used as the sole treatment or as a part of a combination treatments for post-stroke sequlae. Studies were included if they were placebo-controlled or controlled against a drug therapy or no treatment group. Cochrane criteria were used to assess the risk of bias. RESULTS: Our search strategy generated 105 hits, and 25 RCTs met our inclusion criteria. All the included RCTs were associated with a high risk of bias. The majority of BHD plus conventional treatments with response rate showed favorable effects compared to conventional treatments in individual studies. However, a meta-analysis suggested that BHD did not generate a better effect than conventional treatments (n=1534; RR, 1.19; 95% CI 1.14 to 1.25; P<.00001). The results of this systematic review provide no strong evidence for the effectiveness of BHD in the management for post-stroke sequlae. CONCLUSION: This systematic review showed that decoction in BHD for recuperation is effective and safety for stroke with sequlae. However, the total number of RCTs included in the analysis and their methodological quality were too low to draw firm conclusions. Future rigorous RCTs will be necessary to assess the clinical efficacy of HMs in this area.
format Online
Article
Text
id pubmed-3875090
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Global Advances in Health and Medicine
record_format MEDLINE/PubMed
spelling pubmed-38750902014-01-03 14B. Buyang Huanwu Decoction for Post-stroke Sequelae (Qi And Blood Stasis): A Systematic Review of Randomized Controlled Trials Lee, Juah Choi, Tae-Young Ko, Mimi Lee, Jungsup Lee, Myeong Soo Glob Adv Health Med Scientific Abstracts Focus Area: Integrative Approaches to Care OBJECTIVE: Currently, Buyang Huanwu Decoction (BHD) used alone or integrated with Western drugs has been widely used as an alternative and effective method for the treatment of stroke of sequelae in China. Many clinical studies reported the effectiveness ranging from case reports and case series to controlled observational studies and randomized clinical trials, but the evidence for its effect is not clear. Our objective was to evaluate the clinical efficacy of Buyang Huanwu decoction (BHD) in treating sequelae of stroke. METHODS: Thirteen databases were searched from their inception through January 2013. Randomized clinical trials (RCTs) were included if BHD was used as the sole treatment or as a part of a combination treatments for post-stroke sequlae. Studies were included if they were placebo-controlled or controlled against a drug therapy or no treatment group. Cochrane criteria were used to assess the risk of bias. RESULTS: Our search strategy generated 105 hits, and 25 RCTs met our inclusion criteria. All the included RCTs were associated with a high risk of bias. The majority of BHD plus conventional treatments with response rate showed favorable effects compared to conventional treatments in individual studies. However, a meta-analysis suggested that BHD did not generate a better effect than conventional treatments (n=1534; RR, 1.19; 95% CI 1.14 to 1.25; P<.00001). The results of this systematic review provide no strong evidence for the effectiveness of BHD in the management for post-stroke sequlae. CONCLUSION: This systematic review showed that decoction in BHD for recuperation is effective and safety for stroke with sequlae. However, the total number of RCTs included in the analysis and their methodological quality were too low to draw firm conclusions. Future rigorous RCTs will be necessary to assess the clinical efficacy of HMs in this area. Global Advances in Health and Medicine 2013-11 2013-11-01 /pmc/articles/PMC3875090/ http://dx.doi.org/10.7453/gahmj.2013.097CP.S14B Text en © 2013 GAHM LLC. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial- No Derivative 3.0 License, which permits rights to copy, distribute and transmit the work for noncommercial purposes only, provided the original work is properly cited.
spellingShingle Scientific Abstracts
Lee, Juah
Choi, Tae-Young
Ko, Mimi
Lee, Jungsup
Lee, Myeong Soo
14B. Buyang Huanwu Decoction for Post-stroke Sequelae (Qi And Blood Stasis): A Systematic Review of Randomized Controlled Trials
title 14B. Buyang Huanwu Decoction for Post-stroke Sequelae (Qi And Blood Stasis): A Systematic Review of Randomized Controlled Trials
title_full 14B. Buyang Huanwu Decoction for Post-stroke Sequelae (Qi And Blood Stasis): A Systematic Review of Randomized Controlled Trials
title_fullStr 14B. Buyang Huanwu Decoction for Post-stroke Sequelae (Qi And Blood Stasis): A Systematic Review of Randomized Controlled Trials
title_full_unstemmed 14B. Buyang Huanwu Decoction for Post-stroke Sequelae (Qi And Blood Stasis): A Systematic Review of Randomized Controlled Trials
title_short 14B. Buyang Huanwu Decoction for Post-stroke Sequelae (Qi And Blood Stasis): A Systematic Review of Randomized Controlled Trials
title_sort 14b. buyang huanwu decoction for post-stroke sequelae (qi and blood stasis): a systematic review of randomized controlled trials
topic Scientific Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875090/
http://dx.doi.org/10.7453/gahmj.2013.097CP.S14B
work_keys_str_mv AT leejuah 14bbuyanghuanwudecoctionforpoststrokesequelaeqiandbloodstasisasystematicreviewofrandomizedcontrolledtrials
AT choitaeyoung 14bbuyanghuanwudecoctionforpoststrokesequelaeqiandbloodstasisasystematicreviewofrandomizedcontrolledtrials
AT komimi 14bbuyanghuanwudecoctionforpoststrokesequelaeqiandbloodstasisasystematicreviewofrandomizedcontrolledtrials
AT leejungsup 14bbuyanghuanwudecoctionforpoststrokesequelaeqiandbloodstasisasystematicreviewofrandomizedcontrolledtrials
AT leemyeongsoo 14bbuyanghuanwudecoctionforpoststrokesequelaeqiandbloodstasisasystematicreviewofrandomizedcontrolledtrials